Status:
COMPLETED
Rise Study for Depression
Lead Sponsor:
Big Health Inc.
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
This study will examine the efficacy of digital CBT versus waitlist in improving symptoms for adults with Major Depressive Disorder.
Detailed Description
This study aims to examine the effectiveness of app-based digital CBT in individuals with a diagnosis of Major Depressive Disorder. The primary outcomes are depression symptom reduction and engagement...
Eligibility Criteria
Inclusion
- Adults aged ≥22 years old
- Score ≥10 and \<20 on the 8-item Patient Health Questionnaire (PHQ-8)
- Diagnosis of Major Depression
- Current resident of the USA
- Oral and written fluency in English
- Regular access to the internet via a mobile or tablet device using Android (5 or higher) or iOS (13 or higher)
- Participant is able and willing to comply with protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form
Exclusion
- Must not be currently receiving or be expecting to start therapy for depression, anxiety, or sleep during study participation, or have received cognitive behavioral therapy for depression, anxiety, or sleep in the past 12-months
- If on psychotropic medication, this must be stable for at least 60 days
- Past or present psychosis, schizophrenia, or bipolar disorder
- Moderate or greater suicide risk
- Treatment-resistant depression
- Hearing or vision impairment that prevents effective use of the audio-visual content of digital CBT or psychoeducation
- Intellectual disability or any Neurocognitive or Neurodevelopmental disorder that would prevent participants from following study procedures
- Any condition that the investigator believes would make participation in the study not in the best interest of the subject or would preclude successful completion of study activities
- Other exclusion criteria may apply
Key Trial Info
Start Date :
August 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT06003361
Start Date
August 31 2023
End Date
December 21 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Big Health Inc.
San Francisco, California, United States, 94108